A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2.

Luan, Junwen; Lu, Yue; Gao, Shan; Zhang, Leiliang

Luan, Junwen; Lu, Yue; Gao, Shan; Zhang, Leiliang.

Luan J; Institute of Basic Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250062, Shandong, China.
Lu Y; Institute of Basic Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250062, Shandong, China; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250200, Shandong, China.
Gao S; Institute of Basic Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250062, Shandong, China.
Zhang L; Institute of Basic Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250062, Shandong, China. Electronic address: armzhang@hotmail.com.

J Infect ; 81(2): 318-356, 2020 08.

Article in English | MEDLINE | ID: covidwho-46816

Subject(s)

Betacoronavirus/drug effects; Integrins/therapeutic use; Receptors, Virus/drug effects; Spike Glycoprotein, Coronavirus/drug effects; Binding Sites; COVID-19; Coronavirus Infections/drug therapy; Humans; Pandemics; Pneumonia, Viral/drug therapy; Receptors, Immunologic/drug effects; Receptors, Peptide/drug effects; Severe acute respiratory syndrome-related coronavirus/drug effects; SARS-CoV-2; Severe Acute Respiratory Syndrome/drug therapy; Virus Internalization/drug effects; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Virus / Integrins / Spike Glycoprotein, Coronavirus / Betacoronavirus Limits: Humans Language: English Journal: J Infect Year: 2020 Document Type: Article Affiliation country: J.jinf.2020.03.046

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google